Bone, joint and muscle cancer care at UCLA

Care at UCLA for bone, joint and muscle cancer patients is provided through UCLA Health's UCLA Orthopaedic Oncology Program.

The program is part of the UCLA Musculoskeletal Oncology Service. Established in 1980, this service manages all bone and soft-tissue tumors, benign and malignant, primary, recurrent and metastatic as well as tumor-like conditions of bone. UCLA has been a pioneer in the development of limb-sparing surgical strategies for both malignant bone and soft-tissue sarcomas.

Chordoma is a rare, cancerous tumor that develops in the spine and skull base. UCLA provides care for the disease through the UCLA Chordoma Center.

Make an appointment

Please call the UCLA Cancer Hotline at 888-ONC-UCLA (888-662-8252) Monday through Friday, 8am to 5pm.

For more information about insurance, billing, patient forms, map and directions, and more, please visit the UCLA Health website.

To refer a patient

If you are a health care professional and would like to refer a patient to the UCLA Orthopaedic Oncology Program, please call our Physician Referral Service at 1-800-UCLA-MD1 (800-825-2631).

You can also visit the UCLA Health website for more information.

Clinical trials for bone, joint and muscle cancer

Clinical trials are a vital step in discovering new treatments for cancer. UCLA doctors conduct clinical research to find new therapies for bone, joint and muscle tumors, and geneticists also work with precision medicine, which uses your DNA to help pinpoint the best treatment for you. By participating in a clinical trial, you will have access to the most innovative care.

To search for clinical trials at UCLA, please visit UCLA Health's online clinical trial search tool. You can also call the Clinical Trials Hotline at (855) 731-6040.

Learn more about bone, joint and muscle cancer

For more information about bone, joint and muscle cancer and its symptoms, risk factors, and screening and treatment options, please visit the American Cancer Society’s bone cancer page.